1. β-Hydroxybutyrate Exacerbates Hypoxic Injury by Inhibiting HIF-1α-Dependent Glycolysis in Cardiomyocytes—Adding Fuel to the Fire?

   • Xiurui Ma
   • Zhen Dong
   • Junbo Ge

   Original Article Open access 15 October 2021 Pages: 383 - 397

   

2. Protective Role of lncRNA TTN-AS1 in Sepsis-Induced Myocardial Injury Via miR-29a/E2F2 Axis

   • Xinghua Pei
   • Yanhong Wu
   • Wu Lu

   Original Article 14 September 2021 Pages: 399 - 412

   

3. Non-Invasive Local Acoustic Therapy Ameliorates Diabetic Heart Fibrosis by Suppressing ACE-Mediated Oxidative Stress and Inflammation in Cardiac Fibroblasts

   • Liqing Weng
   • Lu Li
   • Xiangqing Kong

   Original Article 14 February 2022 Pages: 413 - 424

   

4. Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice

   • Guangyan Zhang
   • Yin Kang
   • Bradley B. Keller

   Original Article 14 February 2022 Pages: 425 - 436

   

5. SLC7A11/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis

   • Xiyu Zhang
   • Cuiting Zheng
   • Yan Meng

   Original Article 14 July 2021 Pages: 437 - 447

   

6. The Association between Multi-Vessel Coronary Artery Disease and High On-Aspirin Platelet Reactivity

   • Arthur Shiyovich
   • Liat Sasson
   • Leor Perl

   Original Article 14 May 2021 Pages: 449 - 454

   

7. CD36+/CD61+ Microparticles Correlate with the Risk of Percutaneous Cardiac Interventions in Coronary Artery Disease Patients and the Effects of Ticagrelor

   • Xue Zhou
   • Xing Liu
   • Jingjin Che

   Original Article 24 April 2021 Pages: 455 - 465

   

8. Impact of Calcium Channel Blockers on Aspirin Reactivity in Patients with Coronary Artery Disease

   • Afek Kodesh
   • Eli Lev
   • Leor Perl

   Original Article 20 November 2021 Pages: 467 - 473

   

9. Evaluating a Simple Approach to Identify Adults Meeting the 2018 AHA/ACC Cholesterol Guideline Definition of Very High Risk for Atherosclerotic Cardiovascular Disease

   • Paul Muntner
   • Kate K. Orroth
   • Elizabeth A. Jackson

   Original Article 04 March 2021 Pages: 475 - 481

   

10. Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19

    • Laurent Chouchana
    • Nathanaël Beeker
    • on behalf of AP-HP/Universities/Inserm COVID-19 research collaboration, AP-HP Covid CDR Initiative, and “Entrepôt de Données de Santé” AP-HP Consortium”

    Short Communication 17 February 2021 Pages: 483 - 488

    

11. The Effect of Tafamidis on Circulating Endothelial Progenitor Cells in Patients with Transthyretin Cardiac Amyloidosis

    • Osnat Itzhaki Ben Zadok
    • Dorit Leshem-Lev
    • Alon Eisen

    Original Article 22 September 2021 Pages: 489 - 496

    

12. Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure

    • Felix Hofer
    • Niema Kazem
    • Alexander Niessner

    Original Article 03 August 2021 Pages: 497 - 504

    

13. Rationale and Design of the ADIDAS Study: Association Between Dapagliflozin-Induced Improvement and Anemia in Heart Failure Patients

    • Jianping Zeng
    • Yunlong Zhu
    • Yingchun Wang

    Trial Designs Open access 29 March 2021 Pages: 505 - 509

    

14. The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review

    • Qinchao Wu
    • Baochen Bai
    • Xianming Chu

    Review Article 13 April 2021 Pages: 511 - 524

    

15. Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era

    • Mahmoud Allahham
    • A. Lerman
    • Y. Birnbaum

    Review Article 10 July 2021 Pages: 525 - 532

    

16. Efficacy and Safety of the Fixed-Dose Versus Variable-Dose of 4-PCC for Vitamin K Antagonist Reversal: A Comprehensive Systematic Review and Meta-Analysis

    • Keyhan Mohammadi
    • Shakila Yaribash
    • Azita Hajhossein Talasaz

    Review Article 17 April 2021 Pages: 533 - 546

    

17. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?

    • Pedro Castro
    • Marta Palomo
    • Maribel Diaz-Ricart

    Review Article 07 June 2021 Pages: 547 - 560

    

18. The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus

    • Bertram Pitt
    • Gabriel Steg
    • Deepak L. Bhatt

    Review Article Open access 09 November 2021 Pages: 561 - 567

    

19. Dyslipidemia, chronic kidney disease, atherosclerotic cardiovascular disease, and statins

    • Tomoyuki Kawada

    Letter to the Editor 12 November 2021 Pages: 569 - 570

20. Letter to the Editor Regarding “The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus”

    • Yafei Xie
    • Xiaowei Zhang

    Letter to the Editor 24 January 2022 Pages: 571 - 572

21. Response to the Letter on “The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus”

    • Bertram Pitt
    • Gabriel Steg
    • Deepak L. Bhatt

    Letter to the Editor 10 January 2022 Pages: 573 - 573